<DOC>
	<DOCNO>NCT01717846</DOCNO>
	<brief_summary>This proposal test hypothesis Orencia affect apoptosis apoptosis relate genes/biomarkers vivo rheumatoid arthritis ( RA ) patient .</brief_summary>
	<brief_title>Effect Orencia ( Abatacept ) Apoptosis T Cells , B Cells APC Cells Rheumatoid Arthritis</brief_title>
	<detailed_description>Orencia may regulate apoptosis apoptosis relate gene vivo rheumatoid arthritis ( RA ) patient 's cell . To date , study perform evaluate effect Orencia apoptosis RA patient . Primary : To determine effect Abatacept apoptosis T cell , B cell antigen present cell ( APC ) RA patient baseline , 3 month 6 month . Secondary : To evaluate association change apoptosis change disease activity measure ( DAS28/ESR ) 6 month treatment subcutaneous injection abatacept .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Lymphocytosis</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>1 . Over age 18 2 . Meeting ACR Criteria 1987 RA diagnosis 3 . Na√Øve treatment abatacept 4 . Must able understand information Informed Consent 1 . Pregnancy breast feed 2 . Previous exposure abatacept . 3 . History concomitant autoimmune disease ( eg . SLE , PsA etc . ) 4 . Patients history cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Apoptosos</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>T cell , B cell</keyword>
	<keyword>DAS28</keyword>
	<keyword>Clinical Disease activity Index</keyword>
	<keyword>CDAI</keyword>
</DOC>